Open Access

Expression of calcitonin gene-related peptide in the infrapatellar fat pad in knee osteoarthritis patients

  • Jun Aikawa1,
  • Kentaro Uchida1Email author,
  • Shotaro Takano1,
  • Gen Inoue1,
  • Atsushi Minatani1,
  • Masayuki Miyagi1,
  • Dai Iwase1,
  • Hiroyuki Sekiguchi1,
  • Manabu Mukai1 and
  • Masashi Takaso1
Journal of Orthopaedic Surgery and Research201712:65

DOI: 10.1186/s13018-017-0568-1

Received: 25 February 2017

Accepted: 13 April 2017

Published: 21 April 2017

Abstract

Background

The infrapatellar fat pad (IPFP) has been implicated as a possible source of osteoarthritis (OA) development and knee pain due to the production of inflammatory mediators and the existence of nerve fibers within this structure. Calcitonin gene-related peptide (CGRP) is a vasodilatory neuropeptide that is localized to joint tissues and has recently been implicated in the development of knee OA and OA pain. To date, however, the expression levels of CGRP in the IPFP of human knee OA patients have not been examined.

Methods

IFFP and synovial (SYN) tissues were harvested from 100 individuals with radiographic knee OA (unilateral Kellgren/Lawrence [K/L] grades 2–4) during total knee arthroplasty and subjected to immunohistochemical analysis for CGRP localization. In addition, the messenger RNA (mRNA) expression levels of CGRP and cyclooxygenase-2 (COX-2) in the collected tissues were evaluated and compared using real-time PCR analysis of total RNA extracts. CGRP and COX-2 mRNA expression were also compared among individuals with K/L grades 2–4.

Results

CGRP-positive cells were detected in the capillaries within the IPFP and lining layer of SYN tissue. The expression levels of CGRP in the IPFP were positively correlated with COX-2 and were significantly higher than those in SYN tissue. CGRP expression in tissue from the KL4 group was twofold higher than that from the KL2 group.

Conclusions

The IPFP of knee OA patients produces relatively high levels of CGRP, which may be regulated by COX-2 at the transcriptional level. Further studies are needed to determine if CGRP levels are directly linked to OA pathology.

Keywords

Calcitonin gene-related peptide Knee osteoarthritis Infrapatellar fat pad

Background

Knee osteoarthritis (OA) patients often present with cartilage degeneration and joint pain that ranges from moderate to severe. Evidence suggests that several joint tissues, including synovial (SYN) tissue [13], joint capsule [4], and menisci [57], are involved in the development of OA and OA pain. Despite these findings, the mechanisms underlying OA pathology are not fully understood.

The infrapatellar fat pad (IPFP), which is located at the anterior aspect of the knee and is surrounded by the SYN membrane, may contribute to OA development or pain [8, 9]. The IPFP also secretes a number of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), that contribute to OA development [1012]. Further, the IPFP is particularly sensitive to pain and is richly innervated by nerve fibers originating from the posterior tibial nerve [13]. These nerve fibers include peptidergic C-fibers, which are nociceptive and produce a number of neuromodulatory substances [14]. In addition, patients who experience knee pain after total knee arthroplasty often have increased numbers of sensory nerves in the IPFP [15], suggesting that the IPFP serves as a terminus for sensory nerve innervation in the knee joint. Therefore, a better understanding of the expression and regulation of OA-associated molecules in the IPFP may reveal the contribution of this structure to OA development and knee pain.

Among the molecules found in joint tissue is the vasodilatory neuropeptide calcitonin gene-related peptide (CGRP), which binds to the calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) [16]. The levels of CGRP in several human joint tissues are associated with the intensity of OA pain and OA development [4, 5, 1719]. For example, CGRP-positive nerve fibers are increased in the menisci and joint capsule of knee and hip OA patients, respectively [4, 5]. CGRP expression is also increased in SYN of knee OA patients, implicating the involvement of this molecule in inflammation, OA development, and OA pain [1719]. To date, however, CGRP expression in the IPFP has not been investigated in human OA patients.

Here, we attempted to determine the localization and expression levels of CGRP in the IPFP of 100 individuals with knee OA. CGRP expressions levels in the IPFP were also compared to those in the SYN to investigate whether IPFP is a major source of CGRP in the joint tissue of OA patients.

Methods

Patients

Power analysis using an alpha of 0.05 and power of 0.80 was conducted in G*POWER3 to determine a sufficient sample size. Power analysis revealed that 64 samples for CGRP and 97 samples for cyclooxygenase-2 (COX-2) were needed to detect a difference between SYN and IPFP. Therefore, data were collected from 100 participants. The study population consisted of 23 men and 77 women (age: range = 46–89 years, mean ± standard deviation (SD) = 73.3 ± 0.8 years; body mass index (BMI): range = 18.2–36.7, mean ± SD = 25.8 ± 0.4 kg/m2) with radiographic knee OA (unilateral Kellgren/Lawrence [K/L] grades 2 (2/100, 2%), 3 (40/100, 40%), and 4 (58/100, 58%)). All study participants underwent total knee arthroplasty at our institution between March 2015 and January 2017. Informed consent for participation in this study was obtained from each patient on the day before surgery. During the surgery, samples of IPFP and SYN were harvested from each operated knee. A portion of each IPFP and SYN sample was immediately frozen in liquid nitrogen at −80 °C until needed for RNA extraction. The remaining tissue was fixed in 4% paraformaldehyde formalin for 48 h for histological analysis.

Immunohistochemistry

The paraformaldehyde-fixed IPFP and SYN samples were embedded in paraffin, sliced into 3-μm-thick sections, and deparaffinized using xylene. The sections were reacted with primary mouse monoclonal primary antibody against CGRP (Abcam) and rabbit polyclonal primary antibody against COX-2 (Abcam, Cambridge, MA) for 6 h at 4 °C. The sections were further incubated with Alexa Fluor 488 goat anti-rabbit IgG and Alexa Fluor 594 goat anti-mouse IgG secondary antibodies (Thermo Fisher Scientific, Waltham, MA, USA) for 1 h at room temperature. Sections incubated in serum containing no primary antibody were used as negative controls. The fluorescence-stained sections were visualized using fluorescence microscopy (Axiovert 200, Zeiss, Jena, Germany).

Real-time PCR analysis

Total RNA extraction from IPFP and SYN and cDNA synthesis were performed as described previously [18]. PCR primer pair sequences used for real-time PCR analysis were as follows: CGRP-FWD (5′-TTGCCCAGAAGAGAGCCTGTG-3′) and CGRP-REV (5′-TTGTTCTTCACCACACCCCCTG-3′) for CGRP amplification; COX-2-FWD (5′-TGGCTGAGGGAACACAACAG-3′) and COX-2-REV (5′-AACAACTGCTCATCACCCCA-3′) for COX-2 amplification; and GAPDH-FWD (5′-TGTTGCCATCAATGACCCCTT-3′) and GAPDH-REV (5′-CTCCACGACGTACTCAGCG-3′) for GAPDH amplification. Melt curve analysis was used to examine the specificity of the amplified products. The relative messenger RNA (mRNA) expression levels of CGRP and COX-2 were examined by quantitative PCR using the CFX-96 Real-Time PCR Detection System (Bio-Rad, CA, USA). CGRP and COX-2 mRNA expression was normalized to that of the house keeping gene, GAPDH. Further, CGRP and COX-2 mRNA expression levels were compared between IPFP and SYN, and among individuals with K/L grades 2 to 4.

Statistical analysis

Differences in CGRP and COX-2 expression between IPFP and SYN tissues were compared using the paired t test. The relationship between CGRP and COX-2 expression was evaluated using Pearson’s correlation coefficient. Potential statistical outliers that may have influenced the linear regression coefficient analysis were identified using Cook’s distance statistical test. All statistical analyses were performed using SPSS software (v. 19.0; SPSS, Chicago, IL, USA). A p value of <0.05 was considered statistically significant for all analyses, with the exception of the linear regression coefficient analysis, for which a p value of <0.01 was considered statistically significant.

Results

Localization of CGRP in the IPFP and SYN of OA patients

Immunohistochemical analysis was performed to investigate the localization of CGRP in the IPFP tissue of OA patients removed during arthroplastic surgery (Fig. 1a–c). SYN was included for comparative analysis (Fig. 1d–f). Immunostaining revealed that CGRP protein was localized to the capillaries of IPFP (Fig. 1a–c) and the lining layer of the synovium (Fig. 1d–f). No immunostaining was observed in negative control sections.
Fig. 1

Immunostaining of CGRP in the infrapatellar fat pad and synovial tissue of knee OA patients. Infrapatellar fat pad (ac) and synovial tissue (df) stained with (a, c) DAPI (nuclei) or (b, d) CGRP. c, f The merged images. Scale bar = 100 μm

Expression of CGRP and COX-2 in IPFP and SYN of OA patients

The expression of CGRP and COX-2 in the IPFP and SYN of knee OA patients was compared by RT-PCR (Fig. 2). CGRP expression was significantly higher in IPFP than in SYN (Fig. 2a). COX-2 expression was also significantly higher in IPFP compared to SYN (Fig. 2b).
Fig. 2

Real-time PCR analysis of CGRP and COX-2 mRNA expression in the infrapatellar fat pad and synovial tissue of knee OA patients. a CGRP and b COX-2 mRNA expression in the infrapatellar fat pad and synovial tissue of knee OA patients. *Statistically significant difference between IPFP and SYN (p < 0.001). All data are presented as the mean ± standard error (n = 100)

Relationship between CGRP and COX-2 expression levels in the IPFP of OA patients

A correlation between CGRP and COX-2 expression levels was previously identified in the synovium of OA patients [18]. In addition, prostaglandin E2 (PGE2), the enzymatic product of COX-2, was shown to stimulate synovial CGRP gene expression [18]. To investigate the possible regulation of CGRP by COX-2 in IPFP, CGRP and COX-2 expression levels in the IPFP of OA patients were measured (Fig. 3). One IPFP was an outlier for CGRP expression and was therefore excluded from the analysis. Based on the results of the expression analysis, the levels of COX-2 mRNA were positively correlated with those of CGRP in IPFP (Fig. 3).
Fig. 3

Correlation between CGRP and COX-2 mRNA expression levels in the infrapatellar fat pad and SYN tissues of knee OA patients. Correlation between CGRP and COX-2 mRNA expression levels in IPFP tissues harvested from 99 knees of OA patients. The values for one IPFP were removed as outliers

Correlation of CGRP and COX-2 expression among K/L grades

To investigate the relationship between CGRP and COX-2 expression among K/L grades of OA, we analyzed CGRP and COX-2 expression in individuals with K/L grades 2 to 4. CGRP expression was 1.5- and 2.0-fold higher in individuals with K/L grades 3 and 4 compared to those with K/L grade 2, respectively (Fig. 4a). COX-2 expression was 1.4- and 1.7-fold higher in individuals with K/L grades 3 and 4 compared to those with K/L grade 2, respectively (Fig. 4b).
Fig. 4

Relationship between CGRP and COX-2 mRNA expression level and K/L grade. a CGRP and b COX-2 mRNA expression in the infrapatellar fat pad of knee OA patients. All data are presented as the mean ± standard error

Discussion

In the IPFP of knee OA patients, CGRP-expressing cells were observed in the capillaries of adipose tissue. Notably, the expression of CGRP and COX-2 in the IPFP was higher than that in the SYN tissue, although a positive correlation between CGRP and COX-2 expression was detected in both tissues. These findings demonstrate that the IPFP is a source of CGRP in the joint tissue of OA patients.

Previous studies reported that CGRP-positive cells are present in the synovial lining layer of developmental dysplasia of the hip and OA patients [18, 20]. Consistent with previous reports [18], CGRP was localized in the synovial lining layer of knee OA patients. CGRP-positive cells were also detected in the capillaries of the IPFP of knee OA patients. Notably, CGRP expression in the IPFP was significantly higher than that in the SYN. These results suggested that IPFP may be a source of CGRP production in joint tissues.

The IPFP secretes several inflammatory cytokines, including TNF-α and IL-6, at markedly higher levels compared to autologous subcutaneous adipose tissue (SCAT) [11, 12]. CGRP expression is regulated by TNF-α, IL-1β, and PGE2 in several cell types, such as synovial [18], immune [2123], epithelial [24], and neural cells [25, 26]. PGE2 has been shown to stimulate CGRP gene expression in cultured synovial cells [18]. Here, a correlation between CGRP and COX-2 expression was also detected in the IPFP harvested from knees of OA patients, suggesting that the COX-2 pathway may regulate CGRP expression in the IPFP.

The elevation of CGRP levels in OA patients has been suggested to lead to OA development or increased OA pain [4, 5, 17]. Serum levels of CGRP in OA patients are significantly correlated with K/L grade and pain score [17]. Here, CGRP expression in the IPFP of KL grade 4 individuals was 2-fold higher than in that of KL2 patients. CGRP in IPFP may contribute to OA development. However, our study lacked sufficient numbers of KL grade 2 patients for statistical analysis and a healthy control group. Further investigation is needed to reveal the contribution of CGRP to OA pathology.

Several limitations of the present study warrant mention. First, because a non-OA patient population was not included in the study, further experiments are needed to confirm whether CGRP levels are elevated in the IPFP of OA patients compared to non-OA patients. Second, although CGRP levels were higher in IPFP than SYN tissue, determining the presence of a direct causative link between CGRP and pain requires evaluation of the relationship between pain score and CGRP level. Third, in vitro studies using adipocytes and stromal/vascular cells are required to confirm if CGRP is regulated by COX-2/PGE2 in adipose tissue. Finally, the concentration of CGRP protein in IPFP was not determined.

Conclusions

The IPFP of knee OA patients produces relatively high levels of CGRP, which may be regulated by COX-2 at the transcriptional level. Further study is required to determine the contribution of CGRP in IPFP to OA pathology.

Abbreviations

CGRP: 

Calcitonin gene-related peptide

CLR: 

Calcitonin receptor-like receptor

IPFP: 

Infrapatellar fat pad

IL-6: 

Interleukin-6

OA: 

Osteoarthritis

PGE2: 

Prostaglandin E2

RAMP1: 

Receptor activity-modifying protein 1

SYN: 

Synovial tissue

TNF-α: 

Tumor necrosis factor-alpha

Declarations

Acknowledgements

We thank Ms. Yuko Onuki for assistance with the immunohistochemistry analysis.

Funding

This investigation was supported in part by JSPS KAKENHI Grant No. 15K20016, the Uehara Memorial Foundation, a Kitasato University Research Grant for Young Researchers, and research grants from the Parents’ Association of Kitasato University School of Medicine.

Availability of data and materials

The datasets supporting the conclusions of this article are included within the article.

Authors’ contributions

KU, ST, GI, and MT designed the study and performed the data analysis. KU and ST wrote the manuscript. AM, ST, JA, MM (Miyagi), DI, KO, and MM (Mukai) participated in the data collection. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

This study was approved by the Ethics Review Board of Kitasato University (reference number KMEO B13-113). All study participants provided informed consent for the harvesting and use of synovial tissue.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Orthopedic Surgery, Kitasato University School of Medicine

References

  1. Baker K, Grainger A, Niu J, Clancy M, Guermazi A, Crema M, Hughes L, Buckwalter J, Wooley A, Nevitt M, Felson DT. Relation of synovitis to knee pain using contrast-enhanced MRIs. Ann Rheum Dis. 2010;69(10):1779–83.View ArticlePubMedGoogle Scholar
  2. de Lange-Brokaar BJ, Ioan-Facsinay A, Yusuf E, Visser AW, Kroon HM, van Osch GJ, Zuurmond AM, Stojanovic-Susulic V, Bloem JL, Nelissen RG, Huizinga TW, Kloppenburg M. Association of pain in knee osteoarthritis with distinct patterns of synovitis. Arthritis Rheumatol. 2015;67(3):733–40.View ArticlePubMedGoogle Scholar
  3. Yusuf E, Kortekaas MC, Watt I, Huizinga TW, Kloppenburg M. Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review. Ann Rheum Dis. 2011;70(1):60–7.View ArticlePubMedGoogle Scholar
  4. Saxler G, Loer F, Skumavc M, Pfortner J, Hanesch U. Localization of SP- and CGRP-immunopositive nerve fibers in the hip joint of patients with painful osteoarthritis and of patients with painless failed total hip arthroplasties. EurJ Pain. 2007;11(1):67–74.View ArticleGoogle Scholar
  5. Ashraf S, Wibberley H, Mapp PI, Hill R, Wilson D, Walsh DA. Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis. Ann Rheum Dis. 2011;70(3):523–9.View ArticlePubMedGoogle Scholar
  6. Bin SI, Lee SH, Kim CW, Kim TH, Lee DH. Results of arthroscopic medial meniscectomy in patients with grade IV osteoarthritis of the medial compartment. Arthroscopy. 2008;24(3):264–8.View ArticlePubMedGoogle Scholar
  7. Jackson RW, Rouse DW. The results of partial arthroscopic meniscectomy in patients over 40 years of age. J Bone Joint Surg Br. 1982;64(4):481–5.View ArticlePubMedGoogle Scholar
  8. Jacobson JA, Lenchik L, Ruhoy MK, Schweitzer ME, Resnick D. MR imaging of the infrapatellar fat pad of Hoffa. Radiographics. 1997;17(3):675–91.View ArticlePubMedGoogle Scholar
  9. Vahlensieck M, Linneborn G, Schild H, Schmidt HM. Hoffa’s recess: incidence, morphology and differential diagnosis of the globular-shaped cleft in the infrapatellar fat pad of the knee on MRI and cadaver dissections. Eur Radiol. 2002;12(1):90–3.View ArticlePubMedGoogle Scholar
  10. Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, Van Osch GJ, Van Offel JF, Verhaar JA, De Clerck LS, Somville J. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage. 2010;18(7):876–82.View ArticlePubMedGoogle Scholar
  11. Eymard F, Pigenet A, Citadelle D, Flouzat-Lachaniette CH, Poignard A, Benelli C, Berenbaum F, Chevalier X, Houard X. Induction of an inflammatory and prodegradative phenotype in autologous fibroblast-like synoviocytes by the infrapatellar fat pad from patients with knee osteoarthritis. Arthritis Rheumatol. 2014;66(8):2165–74.View ArticlePubMedGoogle Scholar
  12. Ushiyama T, Chano T, Inoue K, Matsusue Y. Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids. Ann Rheum Dis. 2003;62(2):108–12.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Kennedy JC, Alexander IJ, Hayes KC. Nerve supply of the human knee and its functional importance. AmJ Sports Med. 1982;10(6):329–35.View ArticleGoogle Scholar
  14. Bohnsack M, Meier F, Walter GF, Hurschler C, Schmolke S, Wirth CJ, Ruhmann O. Distribution of substance-P nerves inside the infrapatellar fat pad and the adjacent synovial tissue: a neurohistological approach to anterior knee pain syndrome. Arch Orthop Trauma Surg. 2005;125(9):592–7.View ArticlePubMedGoogle Scholar
  15. Lehner B, Koeck FX, Capellino S, Schubert TE, Hofbauer R, Straub RH. Preponderance of sensory versus sympathetic nerve fibers and increased cellularity in the infrapatellar fat pad in anterior knee pain patients after primary arthroplasty. J Orthop Res. 2008;26(3):342–50.View ArticlePubMedGoogle Scholar
  16. Walker CS, Conner AC, Poyner DR, Hay DL. Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends Pharmacol Sci. 2010;31(10):476–83.View ArticlePubMedGoogle Scholar
  17. Dong T, Chang H, Zhang F, Chen W, Zhu Y, Wu T, Zhang Y. Calcitonin gene-related peptide can be selected as a predictive biomarker on progression and prognosis of knee osteoarthritis. Int Orthop. 2015;39(6):1237–43.View ArticlePubMedGoogle Scholar
  18. Minatani A, Uchida K, Inoue G, Takano S, Aikawa J, Miyagi M, Fujimaki H, Iwase D, Onuma K, Matsumoto T, Takaso M. Activation of calcitonin gene-related peptide signaling through the prostaglandin E2-EP1/EP2/EP4 receptor pathway in synovium of knee osteoarthritis patients. J Orthop Surg Res. 2016;11(1):117.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Saito T, Koshino T. Distribution of neuropeptides in synovium of the knee with osteoarthritis. Clin Orthop Relat Res. 2000;376:172–82.View ArticleGoogle Scholar
  20. Wang H, Zhang X, He JY, Zheng XF, Li D, Li Z, Zhu JF, Shen C, Cai GQ, Chen XD. Increasing expression of substance P and calcitonin gene-related peptide in synovial tissue and fluid contribute to the progress of arthritis in developmental dysplasia of the hip. Arthritis Res Ther. 2015;17:4.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Bracci-Laudiero L, Aloe L, Buanne P, Finn A, Stenfors C, Vigneti E, Theodorsson E, Lundeberg T. NGF modulates CGRP synthesis in human B-lymphocytes: a possible anti-inflammatory action of NGF? J Neuroimmunol. 2002;123(1-2):58–65.View ArticlePubMedGoogle Scholar
  22. Bracci-Laudiero L, Aloe L, Caroleo MC, Buanne P, Costa N, Starace G, Lundeberg T. Endogenous NGF regulates CGRP expression in human monocytes, and affects HLA-DR and CD86 expression and IL-10 production. Blood. 2005;106(10):3507–14.View ArticlePubMedGoogle Scholar
  23. Ma W, Dumont Y, Vercauteren F, Quirion R. Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264.7 macrophage cell line. Immunology. 2010;130(3):399–409.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Li W, Hou L, Hua Z, Wang X. Interleukin-1beta induces beta-calcitonin gene-related peptide secretion in human type II alveolar epithelial cells. FASEB J. 2004;18(13):1603–5.PubMedGoogle Scholar
  25. Bowen EJ, Schmidt TW, Firm CS, Russo AF, Durham PL. Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons. J Neurochem. 2006;96(1):65–77.View ArticlePubMedGoogle Scholar
  26. Neeb L, Hellen P, Boehnke C, Hoffmann J, Schuh-Hofer S, Dirnagl U, Reuter U. IL-1beta stimulates COX-2 dependent PGE(2) synthesis and CGRP release in rat trigeminal ganglia cells. PLoSOne. 2011;6(3):e17360.View ArticleGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement